Provided by Tiger Fintech (Singapore) Pte. Ltd.

Myers

15.53
-0.1000-0.64%
Post-market: 15.530.00000.00%16:23 EDT
Volume:92.70K
Turnover:1.44M
Market Cap:580.55M
PE:55.43
High:15.77
Open:15.61
Low:15.35
Close:15.63
Loading ...

Myers Industries Announces Fourth Quarter and Full Year 2024 Results

Business Wire
·
06 Mar

Press Release: Myers Industries Announces Quarterly Dividend

Dow Jones
·
05 Mar

Myers Industries Inc expected to post earnings of 10 cents a share - Earnings Preview

Reuters
·
04 Mar

Evotec Receives $20 Million Research Payment From Bristol Myers Squibb

MT Newswires Live
·
04 Mar

Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb

ACCESS Newswire
·
04 Mar

Press Release: Bristol Myers Squibb Announces Dividend

Dow Jones
·
04 Mar

3 Undervalued Small Caps With Insider Buying To Consider In Your Regional Portfolio

Simply Wall St.
·
03 Mar

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
28 Feb

Bristol Myers Squibb Co. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
27 Feb

Bristol Myers Squibb to Participate in Upcoming Investor Conferences

Business Wire
·
25 Feb

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
25 Feb

Bristol Myers Gets Speedy FDA Review of Opdivo/Yervoy Combo in Certain Colorectal Cancer Patients

Dow Jones
·
24 Feb

U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s Supplemental Biologics License Application for Opdivo® Plus Yervoy® for Patients with Unresectable or Metastatic Microsatellite Instability-High or Mismatch Repair Deficient...

Business Wire
·
24 Feb

Bristol Myers Squibb Co. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
20 Feb

Bristol Myers Cancer Drug Opdivo In Combination With Chemo Shows Improved Overall Survival In Certain Patients With Lung Cancer

Benzinga
·
20 Feb

Bristol Myers announces OS from Phase 3 CheckMate -816 study

TIPRANKS
·
19 Feb

Bristol Myers announces new five-year results from POETYK PSO trial

TipRanks
·
18 Feb

Bristol Myers reports no new safety signals observed in five-year Sotyktu data

TIPRANKS
·
17 Feb

Compugen Updates Filing Structure with Bristol Myers Squibb

TIPRANKS
·
16 Feb

Bristol Myers Squibb Co. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
15 Feb